Hansen Medical Inc - Current report filing
16 8월 2007 - 7:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 14, 2007
HANSEN MEDICAL, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation)
|
|
001-33151
(Commission File Number)
|
|
14-1850535
(I.R.S. Employer Identification
No.)
|
380 North Bernardo Avenue
Mountain View, California 94043
(Address of principal executive offices and zip code)
Registrants telephone number, including area code:
(650) 404-5800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
TABLE OF CONTENTS
Item 2.02. Results of Operations and Financial Condition.
On August 14, 2007, Hansen Medical, Inc. issued a press release announcing its fiscal 2007
second quarter financial results. A copy of the press release is attached as Exhibit 99.1 to this
current report and is incorporated herein by reference.
The information in this current report and in the accompanying exhibit shall not be deemed to
be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities
Act of 1933, as amended. The information contained in this current report and in the accompanying
exhibit shall not be incorporated by reference into any filing with the U.S. Securities and
Exchange Commission made by Hansen Medical, Inc, whether made before or after the date hereof,
regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
99.1
|
|
Press release, dated August 14, 2007, entitled Hansen Medical
Announces 2007 Second Quarter Results.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
|
Hansen Medical, Inc.
(Registrant)
|
|
Date: August 16, 2007
|
/s/
Steven M. Van Dick
|
|
|
Steven M. Van Dick
|
|
|
Chief Financial Officer
|
|
|
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
99.1
|
|
Press release, dated August 14, 2007, entitled Hansen Medical
Announces 2007 Second Quarter Results.
|
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Hansen Medical Inc News Articles